BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ishikawa T. Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients. World J Gastroenterol 2008; 14(40): 6140-6144 [PMID: 18985803 DOI: 10.3748/wjg.14.6140]
URL: https://www.wjgnet.com/1007-9327/full/v14/i40/6140.htm
Number Citing Articles
1
Ahmed Lasfar, Andrew de la Torre, Walid Abushahba, Karine A. Cohen-Solal, Ismael Castaneda, Yao Yuan, Kenneth Reuhl, Andrew Zloza, Elizabeth Raveche, Debra L. Laskin, Sergei V. Kotenko. Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growthOncotarget 2016; 7(31): 49259 doi: 10.18632/oncotarget.10272
2
Asmaa I Gomaa, Imam Waked. Recent advances in multidisciplinary management of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(4): 673-687 doi: 10.4254/wjh.v7.i4.673
3
Kun He, Hua Chen, Tianshou Cao, Jiantao Lin. Elucidation of the Mechanisms and Molecular Targets of Shuanglian Decoction for the Treatment of Hepatocellular Carcinoma Based on Network PharmacologyACS Omega 2021; 6(1): 917 doi: 10.1021/acsomega.0c05550
4
Jun-ichi Okano, Yuki Fujise, Ryo Abe, Ryu Imamoto, Yoshikazu Murawaki. Chemoprevention against hepatocellular carcinomaClinical Journal of Gastroenterology 2011; 4(4): 185 doi: 10.1007/s12328-011-0227-8
5
Manzoor Ahmad Mir, Shariqa Aisha, Shazia Sofi. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies2022; : 1 doi: 10.1016/B978-0-443-18696-7.00010-5
6
Ying Hu, Chuanhua Yu, Banghua Chen, Lei Wang. Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004–2010Journal of Huazhong University of Science and Technology [Medical Sciences] 2012; 32(3): 428 doi: 10.1007/s11596-012-0074-y
7
Chia-Chi Wang, Jia-Horng Kao. How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?Expert Opinion on Pharmacotherapy 2016; 17(7): 911 doi: 10.1517/14656566.2016.1149165
8
Joseph Ahn, Steven L. Flamm. Hepatitis C and hepatocellular carcinoma: New developments in natural history and treatmentCurrent Hepatitis Reports 2009; 8(2): 59 doi: 10.1007/s11901-009-0009-7
9
G. Cenderello, E. Pontali, G. Cassola, A. Torresin. Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reportsInfection 2013; 41(1): 199 doi: 10.1007/s15010-012-0353-3
10
Ahmed Lasfar. Liver Cancer2018;  doi: 10.5772/intechopen.81720
11
Amanda Vestito, Elton Dajti, Fabio Cortellini, Marco Montagnani, Franco Bazzoli, Rocco Maurizio Zagari. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-AnalysisUltraschall in der Medizin - European Journal of Ultrasound 2023; 44(03): e139 doi: 10.1055/a-1657-8825
12
Gabriella Lengyel, János Fehér†. Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinomaOrvosi Hetilap 2010; 151(29): 1177 doi: 10.1556/oh.2010.28925
13
Ahmed Lasfar, Helen Gogas, Andrew Zloza, Howard L Kaufman, John M Kirkwood. IFN-λ Cancer Immunotherapy: New Kid on the BlockImmunotherapy 2016; 8(8): 877 doi: 10.2217/imt-2015-0021
14
Biotechnology in Medical Sciences2014; : 86 doi: 10.1201/b16905-7
15
Jung-Hwan Yu, Ja Kyung Kim, Kwan Sik Lee, Jung Il Lee. Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative TreatmentJournal of Clinical Gastroenterology 2018; 52(6): 557 doi: 10.1097/MCG.0000000000000923
16
Tatyana O Kabilova, Larisa V Kovtonyuk, Evgeniy V Zonov, Elena I Ryabchikova, Nelly A Popova, Valeriy P Nikolin, Vasiliy I Kaledin, Marina A Zenkova, Valentin V Vlassov, Elena L Chernolovskaya. Immunotherapy of hepatocellular carcinoma with small double-stranded RNABMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-338
17
Hie‐Won Hann, Robert Coben, Daniel Brown, Laurence Needleman, Ernest Rosato, Albert Min, Richard S. Hann, Kyong Bin Park, Stephen Dunn, Anthony J. DiMarino. A long‐term study of the effects of antiviral therapy on survival of patients with HBV‐associated hepatocellular carcinoma (HCC) following local tumor ablationCancer Medicine 2014; 3(2): 390 doi: 10.1002/cam4.197
18
Hardeep Kaur, Soma Mondal Ghorai. Immunomodulators and Human Health2022; : 371 doi: 10.1007/978-981-16-6379-6_13
19
Toru Ishikawa. Future perspectives on the treatment of hepatocellular carcinoma with cisplatinWorld Journal of Hepatology 2009; 1(1): 8-16 doi: 10.4254/wjh.v1.i1.8
20
Roniel Cabrera, Renumathy Dhanasekaran, James Caridi, Virgina Clark, Giuseppe Morelli, Consuelo Soldevila-Pico, Joseph Magglioca, David Nelson, Roberto Jose Firpi. Impact of Transarterial Therapy in Hepatitis C-Related Hepatocellular Carcinoma on Long-term Outcomes After Liver TransplantationAmerican Journal of Clinical Oncology 2012; 35(4): 345 doi: 10.1097/COC.0b013e31821631f6